1-5 of 5
Douglas Robinson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 901: The mechanobiome of pancreatic cancer: a viable, targetable drug space

Alexandra Surcel, Eric S. Schiffhauer, Dustin Thomas, Qingfeng Zhu, Robert Anders, Douglas Robinson
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 901.
https://doi.org/10.1158/1538-7445.AM2017-901
Published: 01 July 2017
View article titled, Abstract 901: The mechanobiome of pancreatic cancer: a viable, targetable drug space
Journal Articles

Abstract 4564: Assessment of genetic alterations using next-generation sequencing in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the BOLERO-2 phase III trial.

Jose Baselga, Martine Piccart, Hope Rugo, David Chen, Howard A. Burris, Mario Campone, Shinzaburo Noguchi, Alejandra Perez, Inas Deleu, Mikhail Shtivelband, Louise Provencher, Adnan Derti, Alan Huang, Rob McDonald, Creton Kalfoglou, Douglas Robinson, Tetiana Taran, Tarek Sahmoud, David Lebwohl, Gabriel N. Hortobagyi
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4564.
https://doi.org/10.1158/1538-7445.AM2013-4564
Published: 15 April 2013
View article titled, Abstract 4564: Assessment of genetic alterations using next-generation sequencing in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the BOLERO-2 phase III trial.
Journal Articles

Abstract 4818: The predictive value of a 5-gene signature as a patient pre-selection tool in medulloblastoma for Hedgehog pathway inhibitor therapy

Dereck Amakye, Douglas Robinson, Kristine Rose, Jae Cho, Keith L. Ligon, Thad Sharp, Asifa Haider, Raj Bandaru, Yuichi Ando, Birgit Geoerger, Francois Doz, David Ashley, Darren Hargrave, Michela Casanova, Jordi Rodon, Anne Thomas, Alain Mita, Tobey MacDonald, Mark W. Kieran
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 4818.
https://doi.org/10.1158/1538-7445.AM2012-4818
Published: 15 April 2012
View article titled, Abstract 4818: The predictive value of a 5-gene signature as a patient pre-selection tool in medulloblastoma for Hedgehog pathway inhibitor therapy
Journal Articles

The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors

Fei Huang, Ann Greer, Warren Hurlburt, Xia Han, Rameh Hafezi, Gayle M. Wittenberg, Karen Reeves, Jiwen Chen, Douglas Robinson, Aixin Li, Francis Y. Lee, Marco M. Gottardis, Edwin Clark, Lee Helman, Ricardo M. Attar, Ashok Dongre, Joan M. Carboni
Journal: Cancer Research
Cancer Res (2009) 69 (1): 161–170.
https://doi.org/10.1158/0008-5472.CAN-08-0835
Published: 31 December 2008
View article titled, The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors
Open the PDF for The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors in another window
Includes: Supplementary data
Journal Articles

Protein profiling approaches to identify predictive markers of tumor response to Cetuximab (Erbitux) using xenograft models

Ji Gao, Robert C. Wild, Robert Carney, Keith Ho, Douglas Robinson, Tai W. Wong, Edwin Clark, David Mauro, Ashok R. Dongre
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 730.
Published: 01 May 2005
View article titled, Protein profiling approaches to identify predictive markers of tumor response to Cetuximab (Erbitux) using xenograft models